Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine

Vaccine

Volumn 21, Issue 11-12, 2003, Pages 1180-1186

  Muszkat, Mordechai ^a   Greenbaum, Evgenia ^b   Ben Yehuda, Arie ^a   Oster, Moses ^a   Yeu'l, Efrain ^c   Heimann, Shmuel ^b   Levy, Reuven ^b   Friedman, Gideon ^a   Zakay Rones, Zichria ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

^c HERZOG HOSPITAL   (Israel)

Author keywords

Elderly age group; Influenza; Nasal vaccine

Indexed keywords

HEMAGGLUTININ; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INACTIVATED VACCINE; INFLUENZA VACCINE;

AGED; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; COMMERCIAL PHENOMENA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; MALE; NURSING HOME; PRIORITY JOURNAL; SEROCONVERSION; VACCINATION; VIRUS STRAIN;

ADMINISTRATION, INTRANASAL; AGED; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNITY, MUCOSAL; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINES; INJECTIONS, INTRAMUSCULAR; INSTITUTIONALIZATION; NASAL MUCOSA; NURSING HOMES; VACCINATION; VACCINES, INACTIVATED;

EID: 0037424106     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00481-4     Document Type: Article

References (42)

1. Nichol K.L., Margolis K.L., Wuorenma J., Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N. Engl. J. Med. 331:1994;778-784.
2. Gross P.A., Hermogenes A.W., Sacks H.S., Lau J., Levandowski R.A. The efficacy of influenza vaccine in elderly persons. A meta analysis and review of literature. Ann. Intern. Med. 123:1995;518-527.
3. American College of Physicians Task Force on Adult Immunization. Infectious Diseases Society of America. Guide for adult immunization. 2nd ed. Philadelphia: American College of Physicians; 1990.
4. Provinciali M., Di Stefano G., Muzzioli M.et al. Impaired antibody response to influenza vaccine in institutionalized elderly. Ann. N. Y. Acad. Sci. 717:1994;307-313.
5. Remarque E.J., van Beek W.C., Ligthart G.J.et al. Improvement of the immunoglobulin subclass response to influenza vaccine in elderly nursing-home residents by the use of high-dose vaccines. Vaccine. 11:1993;649-653.
6. Gross P.A., Quinnan G.V., Weksler M.E., Setia U., Douglas R.G. Relation of chronic disease and immune response to influenza vaccine in the elderly. Vaccine. 7:1989;303-308.
7. Odelin M.F., Pozzetto B., Aymard M., Defayolle M., Jolly-Million J. Role of influenza vaccination in the elderly during an epidemic of A/H1N1 virus in 1989/1989. Clinical and serological data. Gerontology. 39:1993;109-116.
8. Beyer W.E.P., Palache A.M., Baljet M., Masurel N. Antibody induction by influenza vaccines in the elderly: a review of the literature. Vaccine. 7:1989;385-394.
9. Beyer W.E.P., Palache A.M., Sprenger M.J.W.et al. Effect of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults. Vaccine. 14:1996;1331-1339.
10. McElhaney J.E., Gravenstein S., Upshaw C.M., Hooton J.W., Krause P., Drinka P. Immune response to influenza vaccination in institutionalized elderly: effect on different T-cell subtypes. Vaccine. 16:1998;403-409.
11. Girodon F., Galan P., Monget A.L., Boutron-Ruault M.C., Brunet-Lecomte P., Preziosi P. Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients. Arch. Intern. Med. 159:1999;748-754.
12. Fulop T. Jr., Wagner J.R., Khalil A., Trottier L., Payette H. Relationship between the response to influenza vaccination and the nutritional status in institutionalized elderly subjects. J. Gerontol. Biol. Sci. Med. Sci. 54:1999;M59-M64.
13. Keitel W.A., Cate T.R., Couch R.B. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am. J. Epidemiol. 127:1988;353-364.
14. Peters N.L., Meiklejohn G., Jahnigen D.W. Antibody response of an elderly population to a supplemental dose of influenza B vaccine. J. Am. Geriatr. Soc. 36:1988;593-599.
15. Govaert T.M.E., Sprenger M.J.W., Dinat G.J., Aretz K., Masurel N., Knottnerus J.A. Immune response to influenza vaccination of elderly people. A randomized double blind placebo controlled trial. Vaccine. 12:1994;1185-1189.
16. Ben-Yehuda A., Danenberg H.D., Zakay-Rones Z., Gross D.J., Freidman G. The influence of sequential annual vaccination and of DHEA administration on the efficacy of the immune response to influenza vaccine in the elderly. Mech. Ageing Dev. 102:1998;299-306.
17. Glathe H., Bigl S., Grosche A. Comparison of humoral immune responses to trivalent influenza split vaccine in young, middle aged and elderly people. Vaccine. 11:1993;702-705.
18. de Bruijn I.A., Remarque E., Beyer W.E.P., le Cessie S., Masurel N., Lighart G.J. Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly. Vaccine. 15:1997;1323-1329.
19. Cornes J.S. Number, size and distribution of Peyer's patches in the human small intestine. Gut. 6:1965;225-233.
20. Finkelstein M.S., Tanner M., Freedman L. Salivary and serum IgA levels in a geriatric outpatient population. J. Immunol. 4:1984;85-91.
21. Fulk R.V., Fedson D.S., Huber M.A., Fitzpatrick J.R., Kasel J.A. Antibody responses in serum and in secretions according to age of recipient and method of administration of A2/Hong Kong/68 inactivated influenza virus vaccine. J. Immunol. 104:1970;8-13.
22. Waldman R.H., Bergman K.C., Stone J.et al. Age dependent antibody response in mice and humans following oral influenza immunization. J. Clin. Immunol. 7:1987;327-331.
23. Waldman R.H., Stone J., Bergman K.C.et al. Secretory antibody following oral influenza immunization. Am. J. Med. Sci. 262:1986;367-371.
24. Powers D.C., Sears S.D., Murphy B.R., Thumar B., Clements M.L. Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines. J. Clin. Microbiol. 27:1989;2666-2671.
25. Powers D.C., Fries L.F., Murphy B.R., Thumar B., Clements M.L. In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory. J. Clin. Microbiol. 29:1991;498-505.
26. Zahradnik J.M., Kasel J.A., Martin R.R., Six H.R., Cate T.R. Immune responses in serum and respiratory secretions following vaccination with a live cold-recombinant (CR35) and inactivated A/USSR/77 (H1N1) influenza virus vaccine. J. Med. Virol. 11:1983;277-285.
27. Belshe R.B., Mendelman P.M., Treanor J.et al. The efficacy of live attenuated, cold adapted, trivalent, intranasal influenza virus vaccine in children. N. Engl. J. Med. 338:1988;1405-1412.
28. Nichol K.L., Mendelman P.M., Mallon K.P.et al. For the live attenuated influenza virus vaccine in healthy adult trial group. Effectiveness of live attenuated influenza virus vaccine in healthy, working adults. JAMA. 282:1999;137-144.
29. Greenbaum E., Furst A., Kiderman A.et al. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine. J. Med. Virol. 65:2001;178-184.
30. Kiderman A., Furst A., Stewart B., Greenbaum E., Morag A., Zakay-Rones Z. A double-blind trial of a new inactivated trivalent, intra-nasal anti-influenza vaccine in general practice: relationship between immunogenicity and respiratory morbidity over the winter of 1997-98. J. Clin. Virol. 20:2001;155-161.
31. Muszkat M., Ben-Yehuda A., Schlein M.H.et al. Local and systemic immune response in community-dwelling elderly after intranasal or intramuscular immunization with inactivated influenza vaccine. J. Med. Virol. 61:2000;100-106.
32. Greenbaum E., Furst A., Kiderman A.et al. Mucosal [SIgA] and serum [IgG] immunologic responses in the community after a single intra-nasal immunization with a new inactivated trivalent influenza vaccine. Vaccine. 20:2000;1232-1239.
33. Wright PF, Pham D, Sannella E, Thompson J. Optimizing the measurement of mucosal immune responses to influenza. In: Conference Program and Abstracts. Options for Control of Influenza III, Cairns, North Queensland, Australia, 4-9 May 1996 [abstract].
34. Tamura S, Hashigucci K, Watanabe K, et al. Protective effects of nasal adjuvant-combined influenza vaccine. In: Brown LE, Hampson AE, Webster RG, editors. Proceedings of the Third International Conference on Options for the Control of Influenza III, Cairns, Qld W-5, Australia. Amsterdam: Elsevier; 1996. p. 285-91.
35. Admon D., Engelhard D., Strauss N., Goldman N., Zakay-Rones Z. Antibody response to influenza immunization in patients after heart transplantation. Vaccine. 15:1997;1518-1522.
36. Boyce T.G., Hsu H.H., Sannella E.C.et al. Safety and immunogenicity of adjuvated and unadjuvated subunit influenza vaccines administered intranasally to healthy adults. Vaccine. 19:2001;217-226.
37. Remarque E.J., Cools H.J.M., Boere T.J., van der Klis R.J., Masurel N., Lighart G.J. Functional disability and antibody response to influenza vaccine in elderly patients in a Dutch nursing home. BMJ. 312:1996;1015.
38. Shapira-Nahor O., Zakay-Rones Z. Local and peripheral cell mediated immune response to influenza virus in mice. J. Clin. Virol. 15:1985;81-91.
39. Zakay-Rones Z., Hadas O., Levy R. Modulation of the lung local immune response by systemic immunization. Med. Microbiol. Immunol. 166:1978;43-50.
40. McElhaney J.E., Meneilly G.S., Lechelt K.E., Beatttie B.L., Bleackley R.C. Antibody response to whole virus and split virus vaccines in successful ageing. Vaccine. 11:1993;1055-1060.
41. Treanor J.J., Mattison R., Dumyati G.et al. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Ann. Intern. Med. 117:1992;625-633.
42. Beyer WEP, Kroon E, Palache AM, Deipersloot RJA, Osterhaus ADME. In: Options for the Control of Influenza IV, Crete, 23-28 September 2000. p. 118.